| 000 | 01851 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250517141556.0 | ||
| 264 | 0 | _c20170905 | |
| 008 | 201709s 0 0 eng d | ||
| 022 | _a1872-6240 | ||
| 024 | 7 |
_a10.1016/j.brainres.2017.02.021 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBaluchnejadmojarad, Tourandokht | |
| 245 | 0 | 0 |
_aEllagic acid exerts protective effect in intrastriatal 6-hydroxydopamine rat model of Parkinson's disease: Possible involvement of ERĪ²/Nrf2/HO-1 signaling. _h[electronic resource] |
| 260 |
_bBrain research _c05 2017 |
||
| 300 |
_a23-30 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntioxidants _xpharmacology |
| 650 | 0 | 4 |
_aApoptosis _xdrug effects |
| 650 | 0 | 4 |
_aCorpus Striatum _xmetabolism |
| 650 | 0 | 4 |
_aDopaminergic Neurons _xmetabolism |
| 650 | 0 | 4 |
_aEllagic Acid _xmetabolism |
| 650 | 0 | 4 |
_aEstrogen Receptor beta _xantagonists & inhibitors |
| 650 | 0 | 4 | _aHeme Oxygenase (Decyclizing) |
| 650 | 0 | 4 | _aMalondialdehyde |
| 650 | 0 | 4 | _aModels, Animal |
| 650 | 0 | 4 | _aMonoamine Oxidase |
| 650 | 0 | 4 | _aNF-E2-Related Factor 2 |
| 650 | 0 | 4 |
_aNeostriatum _xmetabolism |
| 650 | 0 | 4 |
_aNeuroprotective Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aOxidative Stress _xdrug effects |
| 650 | 0 | 4 |
_aOxidopamine _xpharmacology |
| 650 | 0 | 4 |
_aParkinson Disease _xdrug therapy |
| 650 | 0 | 4 |
_aPars Compacta _xmetabolism |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aReactive Oxygen Species |
| 650 | 0 | 4 |
_aSignal Transduction _xdrug effects |
| 650 | 0 | 4 |
_aSubstantia Nigra _xdrug effects |
| 700 | 1 | _aRabiee, Nafiseh | |
| 700 | 1 | _aZabihnejad, Sedigheh | |
| 700 | 1 | _aRoghani, Mehrdad | |
| 773 | 0 |
_tBrain research _gvol. 1662 _gp. 23-30 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.brainres.2017.02.021 _zAvailable from publisher's website |
| 999 |
_c26915051 _d26915051 |
||